The Glidewell Silent Nite Sleep Appliance is Now PDAC-Approved for Medicare (E0486)
Glidewell Receives PDAC-Approval for Silent Nite Sleep Appliance, Making It the Second Silent Nite Appliance Eligible for Medicare Reimbursement Using...
Medicaid
HCA Healthcare Reports Second Quarter 2023 Results
Raises 2023 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), today announced financial and operating results for the second quarter ended June...
Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina
-- Number of subjects increased from 12 to 60 ---- Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve...
NeuroMetrix Reports Q2 2023 Business Highlights
WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the...
UniVida Medical Centers Transitions to eClinicalWorks Cloud EHR to Support Growth and Value-Based Care Model
Miami-based provider improves operations with a unified multidimensional EHRWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that UniVida...
National Minority Quality Forum Urges Policymakers to Ensure Equitable Access to New Respiratory Syncytial Virus Immunizations
Health Equity Action Report shows low-income children of color are at high risk of severe RSVWashington, D.C.--(Newsfile Corp. - July...
MDaudit Enhances Industry Leading Billing Compliance and Revenue Integrity Platform with Groundbreaking AI Capabilities
Insights.ai and SmartScan.ai optimize compliance and revenue integrity by unlocking access to deeper, more meaningful insights and automating key external...
New Research From the Health Equity Collaborative: Healthcare Reform Proposals to Support Diverse Communities
WASHINGTON, DC / ACCESSWIRE / July 20, 2023 / Today, the Health Equity Collaborative (HEC), a diverse community comprised of...
GenHealth.AI Accelerates into Healthcare AI Market with New Funding, Advisor Appointments and Use Cases Across Healthcare
AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off...
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health
Recent Pentech Health acquisition of ZOIA Pharma broadens distribution and access for patients to PKU GOLIKE®GENEVA, SWITZERLAND / ACCESSWIRE /...
Radiology Patient Action Network Urges Congress and CMS to Prevent ‘Cruel’ Cuts to Medicare Access
"With nearly half of Medicare-eligible women having gone years without receiving a mammogram," noted Bob Still, the Executive Director of...
Intellipharmaceutics Announces Second Quarter 2023 Results
TORONTO, ON / ACCESSWIRE / July 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...
Improving Quality in Northwest Clinics Through Chronic Care Management
Northwestern Clinics Embrace CrossTx's Chronic Care Management Solution to Enhance Patient Outcomes and Care CoordinationBOZEMAN, MT / ACCESSWIRE / July...
DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting
DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and OlderMIAMI--(BUSINESS WIRE)--DermaSensor Inc.,...
Claim.MD Achieves HITRUST Risk-Based, 2-year (r2) Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive dataPECOS,...
Claim.MD Achieves HITRUST Risk-Based, 2-year (r2) Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive dataPECOS,...
Samsung Bioepis Releases its Second US Biosimilar Market Report
Details updated average sales price (ASP) trends and market share across all molecules for which biosimilars are availableIncludes Wholesale Acquisition...
New Disease Modifying Drug for Alzheimer’s Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
The first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional...
New Report from Inovalon and Harvard Reveals Notable Differences Between Those Opting for Medicare Advantage vs. Traditional Medicare
Collaborative Research Provides Actionable Insights for Payers and Policymakers on Optimizing Plans to Best Meet the Needs of the Rapidly...